Changes in duration of action of rocuronium following decrease in hepatic blood flow during pneumoperitoneum for...

Area of Science:

• Anesthesiology
• Surgical Oncology
• Pharmacology

Background:

• Laparoscopic surgery often involves CO2 pneumoperitoneum, which can decrease splanchnic perfusion.
• Rocuronium is metabolized by the liver, making liver perfusion a critical factor in its duration of action.
• The impact of altered liver perfusion during laparoscopic surgery on rocuronium's neuromuscular blockade (NMB) requires investigation.

Purpose of the Study:

• To investigate the relationship between liver perfusion and rocuronium's NMB during laparoscopic gynecological surgery.
• To compare rocuronium's NMB in patients undergoing laparoscopic surgery versus laparotomy.

Main Methods:

• A prospective study involving 60 female patients divided into laparoscopy and control (laparotomy) groups.
• Rocuronium administration using a closed-loop feedback system to monitor NMB.
• Assessment of hepatic blood flow via intraoperative ultrasonography at various time points.
• Analysis of the correlation between rocuronium's clinical duration and portal venous blood flow.

Main Results:

• Rocuronium's clinical duration and recovery index were significantly prolonged in the laparoscopy group compared to the control group.
• A significant decrease in portal venous blood flow was observed during pneumoperitoneum in the laparoscopy group.
• A significant correlation was found between the clinical duration of rocuronium and portal venous blood flow.

Conclusions:

• CO2 pneumoperitoneum in laparoscopic surgery may prolong rocuronium-induced NMB due to decreased portal venous blood flow.
• Dosage adjustments for rocuronium may be necessary in laparoscopic gynecological surgery to achieve optimal NMB.
• This study highlights the importance of considering hepatic perfusion changes in anesthetic management during laparoscopic procedures.